BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22648032)

  • 1. Prognostic scoring systems for spinal metastases in the era of anti-VEGF therapies.
    Gregory TM; Coriat R; Mir O
    Spine (Phila Pa 1976); 2013 May; 38(11):965-6. PubMed ID: 22648032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems.
    Wibmer C; Leithner A; Hofmann G; Clar H; Kapitan M; Berghold A; Windhager R
    Spine (Phila Pa 1976); 2011 Nov; 36(23):1977-86. PubMed ID: 21304424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of Tokuhashi scoring systems in spinal metastases, focusing on various primary tumor groups: evaluation of 448 patients in the Aarhus spinal metastases database.
    Wang M; Bünger CE; Li H; Wu C; Høy K; Niedermann B; Helmig P; Wang Y; Jensen AB; Schättiger K; Hansen ES
    Spine (Phila Pa 1976); 2012 Apr; 37(7):573-82. PubMed ID: 21796024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Scoring Systems and Prognostic Factors in Patients With Spinal Metastases From Lung Cancer.
    Tan JH; Tan KA; Zaw AS; Thomas AC; Hey HW; Soo RA; Kumar N
    Spine (Phila Pa 1976); 2016 Apr; 41(7):638-44. PubMed ID: 27018903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of treatment for spinal metastases using scoring system for preoperative evaluation of prognosis.
    Tokuhashi Y; Ajiro Y; Umezawa N
    Spine (Phila Pa 1976); 2009 Jan; 34(1):69-73. PubMed ID: 19127163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of seven preoperative prognostic scoring systems for spinal metastases.
    Leithner A; Radl R; Gruber G; Hochegger M; Leithner K; Welkerling H; Rehak P; Windhager R
    Eur Spine J; 2008 Nov; 17(11):1488-95. PubMed ID: 18787846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimation of life expectancy for selecting surgical procedure and predicting prognosis of extradural spinal metastases].
    Zou XN; Grejs A; Li HS; Høy K; Hansen ES; Bünger C
    Ai Zheng; 2006 Nov; 25(11):1406-10. PubMed ID: 17094910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reviewer's comment concerning "Predictive value of seven preoperative prognostic scoring systems for spinal metastases" (ESJO-D-08-00148R1/A. Leithner et al.).
    Schultheiss M
    Eur Spine J; 2008 Nov; 17(11):1496. PubMed ID: 18818957
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognosis scores of Tokuhashi and Tomita for patients with spinal metastases of renal cancer.
    Ulmar B; Naumann U; Catalkaya S; Muche R; Cakir B; Schmidt R; Reichel H; Huch K
    Ann Surg Oncol; 2007 Feb; 14(2):998-1004. PubMed ID: 17083006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing prognostic factors in patients with spinal metastases: a literature review.
    Popovic M; Lemke M; Zeng L; Chen E; Nguyen J; Thavarajah N; DiGiovanni J; Caporusso F; Chow E
    Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):345-56. PubMed ID: 22812558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Predictive value of three surgical scoring systems for estimation of life expectancy in patients with extradural spinal metastasis].
    Liang TZ; Wan Y; Long GH; Zou XN; Peng XS; Zheng ZM
    Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):875-9. PubMed ID: 21223698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Scoring Algorithms for Predicting Survival Prognosis in Patients With Metastatic Spinal Disease: The Current Status and Future Directions.
    Cui Y; Lei M; Pan Y; Lin Y; Shi X
    Clin Spine Surg; 2020 Oct; 33(8):296-306. PubMed ID: 32604194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative scoring systems and prognostic factors for patients with spinal metastases from hepatocellular carcinoma.
    Chen H; Xiao J; Yang X; Zhang F; Yuan W
    Spine (Phila Pa 1976); 2010 Nov; 35(23):E1339-46. PubMed ID: 20938387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The predictive value of the Tokuhashi revised scoring system for the survival time of patients with spinal metastases].
    Zeng JC; Song YM; Liu H; Gong Q; Li T; Liu LM; Hu YZ; Pei FX; Rao SC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):488-91. PubMed ID: 17593839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of evaluating system for patients with spinal metastases].
    Sun YQ; Cai YB; Rong GW
    Zhonghua Wai Ke Za Zhi; 2003 Aug; 41(8):570-4. PubMed ID: 14505527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bevacizumab in the treatment of breast cancer.
    Koutras AK; Fountzilas G; Makatsoris T; Peroukides S; Kalofonos HP
    Cancer Treat Rev; 2010 Feb; 36(1):75-82. PubMed ID: 19932567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment and evaluation of prognostic factors in spinal metastases of renal cell carcinoma].
    Ulmar B; Catalkaya S; Naumann U; Gerstner S; Cakir B; Schmidt R; Reichel H; Huch K
    Z Orthop Ihre Grenzgeb; 2006; 144(1):58-67. PubMed ID: 16498562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchoscopy for bevacizumab-related hemoptysis.
    Cho YJ; Murgu SD; Colt HG
    Lung Cancer; 2007 Jun; 56(3):465-8. PubMed ID: 17368626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment and prognosis factors in spinal metastases of breast cancer].
    Ulmar B; Richter M; Cakir B; Brunner A; Puhl W; Huch K
    Z Orthop Ihre Grenzgeb; 2005; 143(2):186-94. PubMed ID: 15849638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor inhibition: conflicting roles in tumor growth.
    Saranadasa M; Wang ES
    Cytokine; 2011 Feb; 53(2):115-29. PubMed ID: 20708948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.